BusinessCyclacel’s CYC065 Demonstrates Promising Activity in MYCN-Addicted Neuroblastoma in Preclinical Data Presented at Childhood Cancer 2016By Nasdaq OMXSep 6, 2016, 11:01 AM UTC
BusinessKaryopharm Reports Positive Top-Line Phase 2b STORM Results and Reviews the Planned Development Path for Selinexor in Multiple MyelomaBy Nasdaq OMXSep 6, 2016, 11:00 AM UTC
BusinessApricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Portugal, Ireland and Poland by RecordatiBy Nasdaq OMXSep 6, 2016, 11:00 AM UTC
BusinessCatalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia GravisBy Nasdaq OMXSep 2, 2016, 2:40 PM UTC
BusinessNewLink Genetics to Participate in Baird Healthcare ConferenceBy Nasdaq OMXSep 1, 2016, 11:00 AM UTC
BusinessTonix Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TNX-102 SL in Post-Traumatic Stress DisorderBy Nasdaq OMXAug 29, 2016, 11:00 AM UTC
BusinessPetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA SubmissionBy Nasdaq OMXAug 25, 2016, 12:43 PM UTC
BusinessCancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company UpdatesBy Nasdaq OMXAug 9, 2016, 10:59 PM UTC
